Innovative Drugs Capture a Growing Share of Pharmaceutical Spending

Mean gross and net revenue per drug, by novelty (millions of USD)
Click the buttons below to view data across different dimensions of pharmacological novelty:

Molecular structure Therapeutic target Delivery properties

Trends in unadjusted mean gross and net prescription drug revenue by molecular structure novelty, US, small molecule drugs, 2000–2019

(Please use a modern browser to see the interactive version of this visualization)

Chart: USC Schaeffer Center for Health Policy & EconomicsSource: Authors’ analysis of MEPS, FDA NDC, ChEMBL, and SSR Health dataGet the dataEmbed Download image